Natalia Nemeria

Dr. Natalia Nemeria

Department of Chemistry, Rutgers University, Newark, NJ 07103, USA

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2018 in Free Radical Biology and Medicine
Verified
Journal Article
Closed access
NNNatalia Nemeria
Natalia Nemeria
GGGary Gerfen
Gary Gerfen
PNPradeep Reddy Nareddy
Pradeep Reddy Nareddy
LYLuying Yang
Luying Yang
XZXu Zhang
Xu Zhang
FJFrank Jordan
Frank Jordan

8 May 2020 in Human Molecular Genetics
Verified
Journal Article
Open access
PDF file
JLJoão Leandro
João Leandro
TDTetyana Dodatko
Tetyana Dodatko
JAJan Aten
Jan Aten
NNNatalia Nemeria
Natalia Nemeria
XZXu Zhang
Xu Zhang
SHSander Michel Houten
Sander Michel Houten
Glutaric aciduria type 1 (GA1) is an inborn error of lysine degradation characterized by a specific encephalopathy that is caused by toxic accumulation of lysine degradation intermediates. Substrate reduction through inhibition of DHTKD1, an enzyme upstream of the defective glutaryl-CoA dehydrogenase, has been investigated as a potential therapy, but revealed the existence of an alternative enzymatic source of glutaryl-CoA. Here, we show that loss of DHTKD1 in glutaryl-CoA dehydrogenase-deficient HEK-293 cells leads to a 2-fold decrease in the established GA1 clinical biomarker glutarylcarnitine and demonstrate that oxoglutarate dehydrogenase (OGDH) is responsible for this remaining glutarylcarnitine production. We furthermore show that DHTKD1 interacts with OGDH, dihydrolipoyl succinyltransferase and dihydrolipoamide dehydrogenase to form a hybrid 2-oxoglutaric and 2-oxoadipic acid dehydrogenase complex. In summary, 2-oxoadipic acid is a substrate for DHTKD1, but also for OGDH in a cell model system. The classical 2-oxoglutaric dehydrogenase complex can exist as a previously undiscovered hybrid containing DHTKD1 displaying improved kinetics towards 2-oxoadipic acid.

1 December 2018 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
JZJieyu Zhou
Jieyu Zhou
LYLuying Yang
Luying Yang
OOOliver Ozohanics
Oliver Ozohanics
XZXu Zhang
Xu Zhang
JWJunjie Wang
Junjie Wang
FJFrank Jordan
Frank Jordan
The human 2-oxoglutaric acid dehydrogenase complex (hOGDHc) plays a pivotal role in the tricarboxylic acid (TCA) cycle, and its diminished activity is associated with neurodegenerative diseases. The hOGDHc comprises three components hE1o, hE2o and hE3 and we recently reported functionally active E1o and E2o components, enabling studies on their assembly. No atomic-resolution structure for the hE2o component is currently available, so here we first studied the interactions in the binary subcomplexes (hE1o-hE2o, hE1o-hE3 and hE2o-hE3) to gain insight into the strength of their interactions, and to identify the interaction loci in them. We carried out multiple physico-chemical studies, including fluorescence, hydrogen-deuterium exchange MS (HDX-MS) and chemical cross-linking MS (CL-MS). Our fluorescence studies suggested a strong interaction for the hE1o-hE2o subcomplex, but a much weaker interaction in the hE1o-hE3 subcomplex, and failed to identify any interaction in the hE2o-hE3 subcomplex. The HDX-MS studies gave evidence for interactions in the hE1o-hE2o and hE1o-hE3 subcomplexes comprising full-length components, identifying: (i) the N-terminal region of hE1o, in particular the two peptides 18YVEEM22 and 27ENPKSVHKSWDIF40 as constituting the binding region responsible for the assembly of the hE1o with both the hE2o and hE3 components into hOGDHc, an hE1 region absent in available X-ray structures; (ii) a novel hE2o region comprising residues from both a linker region and from the catalytic domain, as being a critical region interacting with hE1o. The CL-MS identified the loci in the hE1o and hE2o components interacting with each other.

1 July 2017 in Free Radical Biology and Medicine
Verified
Journal Article
Closed access
NNNatalia Nemeria
Natalia Nemeria
GGGary Gerfen
Gary Gerfen
EGElena Guevara
Elena Guevara
PNPradeep Reddy Nareddy
Pradeep Reddy Nareddy
MSMichal Szostak
Michal Szostak
FJFrank Jordan
Frank Jordan

1 September 2018 in Biochimica et Biophysica Acta (BBA) - Bioenergetics
Verified
Journal Article
Closed access
NNNatalia Nemeria
Natalia Nemeria
GGGary Gerfen
Gary Gerfen
LYLuying Yang
Luying Yang
XZXu Zhang
Xu Zhang
FJFrank Jordan
Frank Jordan

29 April 2021 in Life
Verified
Journal Article
Open access
PDF file
NNNatalia Nemeria
Natalia Nemeria
XZXu Zhang
Xu Zhang
JLJoao Leandro
Joao Leandro
JZJieyu Zhou
Jieyu Zhou
LYLuying Yang
Luying Yang
FJFrank Jordan
Frank Jordan
The 2-oxoglutarate dehydrogenase complex (OGDHc) is a key enzyme in the tricarboxylic acid (TCA) cycle and represents one of the major regulators of mitochondrial metabolism through NADH and reactive oxygen species levels. The OGDHc impacts cell metabolic and cell signaling pathways through the coupling of 2-oxoglutarate metabolism to gene transcription related to tumor cell proliferation and aging. DHTKD1 is a gene encoding 2-oxoadipate dehydrogenase (E1a), which functions in the L-lysine degradation pathway. The potentially damaging variants in DHTKD1 have been associated to the (neuro) pathogenesis of several diseases. Evidence was obtained for the formation of a hybrid complex between the OGDHc and E1a, suggesting a potential cross talk between the two metabolic pathways and raising fundamental questions about their assembly. Here we reviewed the recent findings and advances in understanding of protein-protein interactions in OGDHc and 2-oxoadipate dehydrogenase complex (OADHc), an understanding that will create a scaffold to help design approaches to mitigate the effects of diseases associated with dysfunction of the TCA cycle or lysine degradation. A combination of biochemical, biophysical and structural approaches such as chemical cross-linking MS and cryo-EM appears particularly promising to provide vital information for the assembly of 2-oxoacid dehydrogenase complexes, their function and regulation.